Search results for "Thermo Fisher Scientific"

The addition of COVID-19 antibody tests to the portfolio aims to further support the pandemic response on multiple fronts

Program will leverage Ion Torrent Genexus System and Oncomine Precision Assay to advance precision medicine for lung cancer in Asia

New partnership provides Thermo Fisher Scientific the exclusive right to offer ASTar to the market in all geographies

Thermo Fisher Scientific, Beckman Coulter Clinical Diagnostics, and LGC Clinical Diagnostics among those recognized

The TaqPath test is authorized for use with the Everlywell COVID-19 Test Home Collection Kit, which enables individuals to self-collect nasal swab specimens

The agreement allows First Genetics to bring its F-Genetics NGS system and in vitro diagnostic assays for reproductive health testing to Russian labs

The Thermo Scientific Vanquish Core HPLC System is expected to maximize the delivery of precise results with simple, seamless method transfer

In response to the novel coronavirus (SARS-CoV-2) outbreak, Thermo Fisher Scientific has worked rapidly to develop a new multiplex real-time RT-PCR diagnostic kit to enable clinical and public health laboratories to quickly diagnose COVID-19 caused by SARS-CoV-2 infection. 

Co-marketing agreement between Thermo Fisher Scientific and TransMIT allows for high spatial and high mass resolution MSI platform to study complex biological tissues

The Ion Torrent Genexus Dx Integrated Sequencer enables rapid NGS for diagnostic applications and clinical research

The new Thermo Scientific Vanquish Method Development HPLC and UHPLC system delivers robust and validated methods in less time with higher confidence

Genotype data from the kit will also be used to assist epidemiological and genetic surveillance studies to track the ongoing evolution of the virus

Thermo Scientific TSX and TSG Series meet stringent requirements for ensuring the safe storage and efficacy of temperature-sensitive vaccines, including those for COVID-19

Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing

Subsidized technology available as global bodies call for sequencing to confirm COVID-19 mutations

The workflow is designed to minimize the potential for contamination of the food supply and risk to handlers and consumers